Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Arbyn

Showing results (101-110 of 308) with videos related to

Pageof 31
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2013
Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesionsMarkus Schmitt, Christophe Depuydt, Ina Benoy, et al.
Journal of the National Cancer Institute|September 16, 2004
Re: Have we resolved how to triage equivocal cervical cytology?Marc Arbyn, Joakim Dillner, Marc Van Ranst, et al.
Expert Review of Vaccines|November 14, 2019
Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursorsLan Xu, Amanda Selk, Suzanne M Garland, et al.
Plos One|August 7, 2015
Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 YearsEllinor Östensson, Susanna Alder, K Miriam Elfström, et al.
Plos One|May 27, 2015
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 yearsEllinor Östensson, Susanna Alder, K Miriam Elfström, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 16, 2010
Cervical cytology biobanks as a resource for molecular epidemiologyMarc Arbyn, Kristin Andersson, Christine Bergeron, et al.
Vaccine|September 5, 2006
Chapter 9: Clinical applications of HPV testing: a summary of meta-analysesMarc Arbyn, Peter Sasieni, Chris J L M Meijer, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 15, 2017
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening programJean-Jacques Baldauf, Muriel Fender, Christine Bergeron, et al.
Cancer Epidemiology|August 23, 2011
Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: a hierarchical model using multi-center dataEileen M Stock, James D Stamey, Rengaswamy Sankaranarayanan, et al.
The Lancet. Global Health|December 9, 2019
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysisMarc Arbyn, Elisabete Weiderpass, Laia Bruni, et al.
Pageof 31

Showing results (101-110 of 308) with videos related to

Sort By:
Pageof 31
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2013
Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesionsMarkus Schmitt, Christophe Depuydt, Ina Benoy, et al.
Journal of the National Cancer Institute|September 16, 2004
Re: Have we resolved how to triage equivocal cervical cytology?Marc Arbyn, Joakim Dillner, Marc Van Ranst, et al.
Expert Review of Vaccines|November 14, 2019
Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursorsLan Xu, Amanda Selk, Suzanne M Garland, et al.
Plos One|August 7, 2015
Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 YearsEllinor Östensson, Susanna Alder, K Miriam Elfström, et al.
Plos One|May 27, 2015
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 yearsEllinor Östensson, Susanna Alder, K Miriam Elfström, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 16, 2010
Cervical cytology biobanks as a resource for molecular epidemiologyMarc Arbyn, Kristin Andersson, Christine Bergeron, et al.
Vaccine|September 5, 2006
Chapter 9: Clinical applications of HPV testing: a summary of meta-analysesMarc Arbyn, Peter Sasieni, Chris J L M Meijer, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 15, 2017
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening programJean-Jacques Baldauf, Muriel Fender, Christine Bergeron, et al.
Cancer Epidemiology|August 23, 2011
Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: a hierarchical model using multi-center dataEileen M Stock, James D Stamey, Rengaswamy Sankaranarayanan, et al.
The Lancet. Global Health|December 9, 2019
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysisMarc Arbyn, Elisabete Weiderpass, Laia Bruni, et al.
Pageof 31